Virtify offers a comprehensive suite of products and services delivering Structured Content Management (SCM) to help life sciences companies manage labeling, disclosure and documentation more efficiently while improving compliance. The company emphasizes deep domain expertise in life sciences and counts leading pharmaceutical, biotechnology and medical device makers among its partners. Virtify’s solutions are positioned to enable customers to compete more effectively by streamlining regulatory and content workflows. The firm is based in Cambridge, MA. In current filings Virtify reported raising equity in a $3 million tranche out of a $3.5 million offering. In 2010 Virtify previously secured $15 million in growth equity financing from Tudor Ventures to support expansion in the U.S., Europe and other global markets. Virtify offers the Virtx enterprise content compliance software suite, a web-based environment for managing regulated content across the product lifecycle from pre-clinical through product registration to commercialization. The software helps organizations reduce time, risk, and costs by managing and automating complex regulatory compliance and content exchange requirements. The company secured $15M in growth equity financing led by Tudor Ventures. Virtify will use the funds to accelerate Virtx's entrance into the life sciences market. Planned expansions include growing operations, engineering, sales and marketing in the U.S., Europe and other key markets.

Total raised

$18M

Funding rounds

2

Latest round

Equity

Latest activity

Aug 2012